IMC Chicago LLC Buys New Shares in VanEck Pharmaceutical ETF (NASDAQ:PPH)

IMC Chicago LLC bought a new stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 10,383 shares of the company’s stock, valued at approximately $896,000. IMC Chicago LLC owned approximately 0.16% of VanEck Pharmaceutical ETF as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently bought and sold shares of PPH. Adamsbrown Wealth Consultants LLC purchased a new position in shares of VanEck Pharmaceutical ETF in the third quarter valued at about $7,030,000. AAFMAA Wealth Management & Trust LLC lifted its position in shares of VanEck Pharmaceutical ETF by 155.3% in the third quarter. AAFMAA Wealth Management & Trust LLC now owns 35,319 shares of the company’s stock valued at $3,356,000 after acquiring an additional 21,482 shares in the last quarter. Stratos Wealth Advisors LLC lifted its position in shares of VanEck Pharmaceutical ETF by 40.7% in the third quarter. Stratos Wealth Advisors LLC now owns 13,059 shares of the company’s stock valued at $1,241,000 after acquiring an additional 3,778 shares in the last quarter. WT Wealth Management lifted its position in shares of VanEck Pharmaceutical ETF by 6.8% in the third quarter. WT Wealth Management now owns 53,660 shares of the company’s stock valued at $5,080,000 after acquiring an additional 3,424 shares in the last quarter. Finally, Burke & Herbert Bank & Trust Co. lifted its position in shares of VanEck Pharmaceutical ETF by 35.7% in the third quarter. Burke & Herbert Bank & Trust Co. now owns 8,800 shares of the company’s stock valued at $836,000 after acquiring an additional 2,315 shares in the last quarter.

VanEck Pharmaceutical ETF Stock Down 0.2 %

Shares of VanEck Pharmaceutical ETF stock opened at $89.18 on Tuesday. The stock’s 50-day simple moving average is $87.74 and its 200-day simple moving average is $91.69. VanEck Pharmaceutical ETF has a 52 week low of $84.48 and a 52 week high of $99.51. The company has a market capitalization of $556.48 million, a price-to-earnings ratio of 21.04 and a beta of 0.72.

VanEck Pharmaceutical ETF Increases Dividend

The company also recently announced a dividend, which was paid on Monday, December 30th. Stockholders of record on Friday, December 27th were issued a $0.411 dividend. This is a boost from VanEck Pharmaceutical ETF’s previous dividend of $0.36. The ex-dividend date of this dividend was Friday, December 27th.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.